T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.17% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
UGI
UGI
$7.53B
| $3.82M | ﹤0.01% |
98,930
-690
| -0.7% | -$26.7K |
|
|
FSTX
1452
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $3.82M | ﹤0.01% |
609,654
-179,936
| -23% | -$606K |
|
|
AVNS
1453
DELISTED
Avanos Medical
AVNS
| $3.74M | ﹤0.01% |
136,714
+174
| +0.1% | +$5K |
|
1454
CVRx
CVRX
$78.3M
| $3.72M | ﹤0.01% |
618,649
+14,173
| +2% | +$81.5K |
|
|
NXDR
1455
Nextdoor Holdings
NXDR
$986M
| $3.71M | ﹤0.01% |
1,121,926
+175,231
| +19% | +$688K |
|
1456
Old Republic International
ORI
$10.3B
| $3.68M | ﹤0.01% |
164,642
-8,798
| -5% | -$204K |
|
1457
Dolby
DLB
$5.84B
| $3.68M | ﹤0.01% |
51,381
+2,935
| +6% | +$222K |
|
1458
Unum
UNM
$14.5B
| $3.62M | ﹤0.01% |
106,445
+25,641
| +32% | +$868K |
|
1459
Hancock Whitney
HWC
$6.34B
| $3.61M | ﹤0.01% |
81,463
+6,726
| +9% | +$320K |
|
1460
Aecom
ACM
$7.86B
| $3.6M | ﹤0.01% |
55,220
-1,147
| -2% | -$80.2K |
|
1461
Huntsman Corp
HUN
$1.78B
| $3.58M | ﹤0.01% |
126,215
+4,871
| +4% | +$165K |
|
|
GMS
1462
DELISTED
GMS Inc
GMS
| $3.55M | ﹤0.01% |
79,857
+362
| +0.5% | +$17.2K |
|
|
SNV
1463
DELISTED
Synovus
SNV
| $3.52M | ﹤0.01% |
97,551
+23,475
| +32% | +$971K |
|
1464
Novartis
NVS
$290B
| $3.5M | ﹤0.01% |
41,383
+1,881
| +5% | +$165K |
|
1465
Sprouts Farmers Market
SFM
$8.03B
| $3.49M | ﹤0.01% |
137,762
-27,309
| -17% | -$758K |
|
1466
Lear
LEA
$8.16B
| $3.49M | ﹤0.01% |
27,695
+732
| +3% | +$96.5K |
|
|
HI
1467
DELISTED
Hillenbrand
HI
| $3.45M | ﹤0.01% |
84,319
-303
| -0.4% | -$12.7K |
|
|
SUMO
1468
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
| $3.4M | ﹤0.01% |
454,516
-5,287
| -1% | -$46.3K |
|
1469
Brixmor Property Group
BRX
$9.12B
| $3.39M | ﹤0.01% |
167,933
+20,987
| +14% | +$496K |
|
1470
Patria Investments
PAX
$1.79B
| $3.36M | ﹤0.01% |
253,956
| – | – |
|
1471
Ingredion
INGR
$6.54B
| $3.32M | ﹤0.01% |
37,660
-4,241
| -10% | -$380K |
|
1472
AMC Entertainment Holdings
AMC
$2.35B
| $3.3M | ﹤0.01% |
24,334
-1,485
| -6% | -$216K |
|
1473
Compass
COMP
$10.2B
| $3.28M | ﹤0.01% |
+908,710
| New | +$4.97M |
|
1474
Prosperity Bancshares
PB
$8.95B
| $3.25M | ﹤0.01% |
47,613
+5,658
| +13% | +$389K |
|
1475
ManpowerGroup
MAN
$2.61B
| $3.25M | ﹤0.01% |
42,533
-641
| -1% | -$56.1K |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.